Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2001 1
2002 4
2004 1
2006 1
2008 1
2009 3
2010 2
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Phillips KA, et al. J Clin Psychiatry. 2001 Feb;62(2):87-91. doi: 10.4088/jcp.v62n0203. J Clin Psychiatry. 2001. PMID: 11247107 Free PMC article. Clinical Trial.
Baseline BABS scores did not contribute significantly to endpoint BDD-YBOCS scores in a regression analysis. CONCLUSION: Degree of delusionality did not predict fluvoxamine response, and delusionality significantly improved. These findings are preliminary and requir …
Baseline BABS scores did not contribute significantly to endpoint BDD-YBOCS scores in a regression analysis. CONCLUSION: Degree of delusiona …
Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T, Kishi T, Okochi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Tsunoka T, Inada T, Ozaki N, Iwata N. Okumura T, et al. Neuropsychobiology. 2010;61(2):57-63. doi: 10.1159/000265130. Epub 2009 Dec 12. Neuropsychobiology. 2010. PMID: 20016223
In addition, we performed an association analysis between NOS1 and the efficacy of fluvoxamine treatment in 117 MDD patients. We defined a clinical response as a decrease of more than 50% in baseline SIGH-D (Structured Interview Guide for the Hamilton Rating Scale for Depr …
In addition, we performed an association analysis between NOS1 and the efficacy of fluvoxamine treatment in 117 MDD patients. We defined a …
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
Higuchi H, Sato K, Yoshida K, Takahashi H, Kamata M, Otani K, Yamaguchi N. Higuchi H, et al. Psychiatry Clin Neurosci. 2008 Jun;62(3):301-6. doi: 10.1111/j.1440-1819.2008.01797.x. Psychiatry Clin Neurosci. 2008. PMID: 18588590 Free article.
However, a significant difference was observed in the mean factor 3 scores from 1 week onwards between the non-severe responders and non-responders. Furthermore, the fluvoxamine response rate in the severe patients was 75% and higher than that of the non-severe pati …
However, a significant difference was observed in the mean factor 3 scores from 1 week onwards between the non-severe responders and non-res …
Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
Tsunoka T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Inada T, Ozaki N, Iwata N. Tsunoka T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):875-9. doi: 10.1016/j.pnpbp.2009.04.007. Epub 2009 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19386277
From these results, it has been suggested that abnormalities in Group II mGluRs might be involved in the pathophysiology of mood disorders, including MDD) and BP, and may influence the clinical response to treatment with SSRIs in MDD. Therefore, we studied the association …
From these results, it has been suggested that abnormalities in Group II mGluRs might be involved in the pathophysiology of mood disorders, …
Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Ozaki N, Iwata N. Kishi T, et al. Neuropsychobiology. 2009;59(4):234-8. doi: 10.1159/000226612. Epub 2009 Jul 2. Neuropsychobiology. 2009. PMID: 19571598
BACKGROUND: Sleep-wake disturbance, frequently observed in major depressive disorder (MDD), negatively influences clinical status. Treatment with antidepressants also reportedly affects circadian rhythms. ...METHODS: The scores of the MDD patients in this study on the 17 i …
BACKGROUND: Sleep-wake disturbance, frequently observed in major depressive disorder (MDD), negatively influences clinical status. Tr …
Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder.
Heidari M, Zarei M, Hosseini SM, Taghvaei R, Maleki H, Tabrizi M, Fallah J, Akhondzadeh S. Heidari M, et al. Int Clin Psychopharmacol. 2014 Nov;29(6):344-50. doi: 10.1097/YIC.0000000000000043. Int Clin Psychopharmacol. 2014. PMID: 24850229 Clinical Trial.
All patients received fluvoxamine (100 mg/day) for the first 4 weeks, followed by 200 mg/day for the rest of the trial. The patients were assessed using the Y-BOCS and the adverse event checklists at baseline, and the second, fourth, sixth, and eighth week. ...There was no …
All patients received fluvoxamine (100 mg/day) for the first 4 weeks, followed by 200 mg/day for the rest of the trial. The patients …
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L. Di Bella D, et al. Pharmacogenomics J. 2002;2(3):176-81. doi: 10.1038/sj.tpj.6500090. Pharmacogenomics J. 2002. PMID: 12082589 Clinical Trial.
No significant differences in allele/genotype distribution of the 5-HTTLPR were found between 191 controls and OCD. No differences in fluvoxamine response in the three genotypes groups in OCD were found, considering Yale-Brown Obsessive Compulsive Scale (YBOCS) tota …
No significant differences in allele/genotype distribution of the 5-HTTLPR were found between 191 controls and OCD. No differences in flu …
Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.
Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, Klein R, Davies M, Sweeney M, Abikoff H, Hack S, Klee B, Bergman RL, Lynn D, McCracken J, March J, Gammon P, Vitiello B, Ritz L, Roper M; Research Units on Pediatric Psychopharmacology Anxiety Study Group. Walkup J, et al. J Child Adolesc Psychopharmacol. 2002 Fall;12(3):175-88. doi: 10.1089/104454602760386879. J Child Adolesc Psychopharmacol. 2002. PMID: 12427292 Clinical Trial.
Response was defined based on Clinical Global Impression criteria. ...CONCLUSION: The current findings concerning extended treatment of pediatric anxiety disorders are only preliminary, because treatment was uncontrolled. Results suggest that an initial fluvoxami …
Response was defined based on Clinical Global Impression criteria. ...CONCLUSION: The current findings concerning extended tre …
Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.
Saito S, Takahashi N, Ishihara R, Ikeda M, Suzuki T, Kitajima T, Yamanouchi Y, Iwata N, Yamada M, Yoshida K, Inada T, Ozaki N. Saito S, et al. Neuropsychobiology. 2006;54(4):226-30. doi: 10.1159/000100777. Epub 2007 Mar 15. Neuropsychobiology. 2006. PMID: 17356306 Clinical Trial.
The purpose of this study was to investigate whether the VAMP2 gene is associated with clinical responses to a specific antidepressant, fluvoxamine. METHODS: A total of 106 patients with major depressive disorder were given fluvoxamine (50-200 mg/day) for 8 weeks and asses …
The purpose of this study was to investigate whether the VAMP2 gene is associated with clinical responses to a specific antidepressan …
15 results